A phase III study of Aviptadil in sarcoidosis
Phase of Trial: Phase III
Latest Information Update: 06 Oct 2016
At a glance
- Drugs Aviptadil (Primary)
- Indications Pulmonary sarcoidosis
- Focus Therapeutic Use
- 06 Oct 2016 According to a Relief Therapeutics media release, European regulators have indicated that a single pivotal Phase III trial would be sufficient to support approval.
- 29 Jul 2016 New trial record
- 27 Jul 2016 According to Relief Therapeutics media release, top-line data is expected in 2018.